FDA Grants Priority Review to Tzield for Early Chi...
Category : Clinical Trial Update 7 January 2026The US FDA has moved fast. It has accepted a priority review for Sanofi’s supplemental biologi...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Endeavor Health Joins Trial to Diagnose CTE in Liv...
Category : Clinical Trial Update 7 January 2026For decades, chronic traumatic encephalopathy (CTE) could only be confirmed after death. That may b...
Bambusa Therapeutics Doses First Patient With BBT0...
Category : Clinical Trial Update 7 January 2026Bambusa Therapeutics has reached a key clinical milestone. The company has dosed the first patient i...
AstraZeneca’s Baxdrostat Shows Strong Phase III Re...
Category : Clinical Trial Update 6 January 2026AstraZeneca has reported encouraging phase III clinical data for baxdrostat, a first-in-class oral a...
GenEditBio Secures US FDA IND Clearance for First-...
Category : Clinical Trial Update 6 January 2026The US Food and Drug Administration has cleared the IND application for GEB-101, enabling the compan...
Latest Newsletter Post
-
Bambusa Therapeutics Doses First Pa..
7 January 2026
-
Endeavor Health Joins Trial to Diag..
7 January 2026
-
FDA Grants Priority Review to Tziel..
7 January 2026
-
MetaVia’s DA-1726 Delivers Rapid, S..
6 January 2026
-
Delova Reports Positive Phase 3 Res..
6 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com